{"id":616194,"title":"Qualifying notice for Zynlonta (284436) - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-03-02","captureTimestamp":"2026-03-02T18:03:44.452000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/notice-compliance/conditions/qualifying-notice-zynlonta-284436.html","snippet":"Qualifying notice for Zynlonta (284436) Biologic and Radiopharmaceutical Drugs Directorate 100 Eglantine Driveway LCDC Building Tunney’s Pasture, A.L. 0601C Ottawa ON K1A 0K9 Dossier ID: e277127 Control number: 284436 Swedish Orphan Biovitrum AB (Publ) c/o [employee name removed]…","rawSnapshotUrl":"/api/snapshots/raw/616194","browseUrl":"https://replay.healtharchive.ca/job-6/20260302180344/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/notice-compliance/conditions/qualifying-notice-zynlonta-284436.html#ha_snapshot=616194","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}